糖尿病肥満モデルラットにおけるカナグリフロジン投与早期のGFR低下メカニズムについての検討

Key Word：
Type 2 diabetic model（2型糖尿病モデル）、Canagliflozin（カナグリフロジン）、Glomerular Filtration Rate （GFR：糸球体濾過量）

Kasumi Kikuchi^１、Miyuki Murata^１、Yasushi Kageyama^２、Masami Shinohara^２、Tomohiko Sasase^３、Kousuke Noda^１、Susumu Ishida^１ 

^１Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan、^２Tokyo Animal & Diet Department, CLEA Japan, Inc., Tokyo, Japan、³Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan

For more details, please click here (Google Search)

• 第65回 日本腎臓学会学術総会：Kobe International Conference Center in Hyogo, Japan
• June 10-12, 2022

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

 https://www.clea-japan.com/en/products/diabetes/item_a0150

 https://www.clea-japan.com/products/diabetes/item_a0150

Inquiry（お問い合わせ）

If you have any questions, please feel free to contact us.